The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Stopped early · Not applicable
Conditions studied: Diabetic Foot Ulcers
In brief
The purpose of this study is to assess the mechanism of action of the Unite Biomatrix and compare its performance with the standard of care, saline moistened gauze, for the treatment of diabetic foot ulcers.
Key facts
- Study ID
- NCT00958711
- Run by
- Baxter Healthcare Corporation
- People needed
- 90
- Starts
- 2009-01-01
- Expected to finish
- 2012-05-01
- Last updated by the study team
- 2019-12-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A full thickness diabetic foot ulcer with a viable wound bed free of necrotic material (grade 1 on Wagner scale).
- Diagnosis of diabetes mellitus (type I or II) adequately controlled.
- The ulcer is greater than 4 weeks duration.
- Three or fewer ulcers separated by > 3.0 cm distance.
- Post-debridement, the ulcer size must be between 1 and 10 sq cm2.
- Ankle/brachial index is between 0.7 to 1.2 and or one of the following must be present:
- transcutaneous partial pressure oxygen (TcPO2) > 30 mmHg at the ankle
- toe pressure of >40mm Hg or a Doppler waveform consistent with adequate flow in the foot (biphasic or triphasic)
- At least 18 years old.
- Able and willing to provide a voluntary written informed consent.
- Able and willing to wear an off-loading orthopedic shoe.
- Able and willing to attend scheduled follow-up visits and study related exams.
You may not qualify if…
- Greater than 30% reduction in wound size during first week of observation by the investigator.
- Ulcer with exposed tendon or bone.
- Gross clinical infection at the study ulcer site including cellulitis and osteomyelitis.
- Gangrene.
- Active Charcot's disease as determined by clinical and radiographic examination.
- Ulcer of a non-diabetic pathophysiology (e.g., rheumatoid, radiation-related, and vasculitis related ulcers).
- Known severe anemia.
- Known serum albumin < 2.5.
- Renal failure with Creatinine > 2.5.
- Rheumatoid arthritis (and other collagen vascular disease), vasculitis, sickle cell disease, HIV.
- Severe liver disease as defined by the treating physician or patient's primary care physician.
- Malignancy at or near the ulcer site.
- Any condition judged by the investigator that would cause the study to be detrimental to the patient.
- Presence of a hematology, clinical, chemistry or other test obtained within 7 days of screening that is outside the normal range for the laboratory and is determined to be clinically significant by the investigator.
- Received another investigational device or drug within 30 days of Day 0.
- Radiation therapy, chemotherapy or immunosuppressive therapy within 30 days of enrollment.
- Received another allograft, autograft or xenograft within 30 days of the Day 0.
- Known allergy to equine derived tissue.
- Alcohol or drug abuse, defined as current medical treatment for substance abuse.
- Pregnant or nursing women.
Where it is running
- University of California - San Diego — San Diego, California, United States
- University of Miami, Miller School of Medicine — Miami, Florida, United States
- Aiyan Diabetes Center — Evans, Georgia, United States
- Foot & Ankle Associates of Central Illinois, LLC — Springfield, Illinois, United States
- Eastern Carolina Foot and Ankle — Greenville, North Carolina, United States
- Foot and Ankle East — Greenville, North Carolina, United States
- Carolina East Family Medicine — Greenville, North Carolina, United States
- Family Foot & Ankle Physicians — Greenville, North Carolina, United States
- Comprehensive Wound Care Thoracic & Vascular Associates of Kinston P.A. — Kinston, North Carolina, United States
- The Foot & Ankle Associates of North Carolina, PLLC — Rocky Mount, North Carolina, United States
- Martin Foot and Ankle — York, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.